If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Product Launch » Market Entry and Oncology
Download FREE Excerpt
8 Info Graphics
17 Data Graphics
2 Best Practices
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Educating the marketplace about a new product is part of every new product launch. For oncology products, Key Opinion Leaders (KOLs) are among the most important education targets as they can help shape treatment practices. What's not clear is what are the best tactics, timing and activities for engaging and educating thought leaders about new oncology therapies.
Best Practices, LLC conducted this research to identify the best timing for informing KOLS as well as the most effective activities for engaging thought leaders. The study also discusses the identification of KOL segments that align with the new therapy, the role of advisory boards and managing clinical trials to engage thought leaders. Oncology launch leaders can use this study to compare their KOL engagement and education tactics and strategies with those used by industry leaders.
The benchmark class includes 34 executives and managers at 26 leading pharmaceutical, biotech and medical device companies. In addition, deep-dive executive interviews were conducted with selected participants to provide qualitative insights and emerging trends.
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.